期刊文献+

不同胃癌细胞系中B7-H1分子的表达水平及定位 被引量:3

THE EXPRESSIONS AND LOCALIZATIONS OF B7-H1 IN DIFFERENT GASTRIC CANCER CELL LINES
下载PDF
导出
摘要 目的通过检测胃癌细胞系SGC7901/VCR、SGC7901和BGC-823,以及永生化胃上皮细胞系GES中B7-H1的表达,探讨B7-H1与胃癌的发生及多药耐药(MDR)的关系。方法上述细胞系培养于含10%灭活胎牛血清的RPMI-1640培养基中,利用RT-PCR技术、细胞免疫化学染色以及细胞免疫荧光染色技术与流式细胞术检测4种细胞系中B7-H1 mRNA与B7-H1蛋白的表达情况,并比较其在4种细胞系中的表达强度。结果B7-H1 mRNA在4种细胞系中均有表达,表达强度按照GES-1、BGC-823、SGC-7901、SGC-7901/VCR的顺序递增;细胞免疫化学染色与免疫荧光染色表明,B7-H1蛋白主要表达在上述细胞的细胞膜和少量细胞浆中,结合流式细胞术检测进一步证实,B7-H1蛋白在4种细胞系中的表达结果与mRNA的表达一致。结论B7-H1表达在胃上皮细胞上,可能通过抑制机体免疫反应,促进胃癌细胞生长及MDR基因表达。 Objective B7-H1 is a recently identified co-stimulatory molecule expressed on APCs and can inhibit the activation and function of T lymphocytes. This research is to study if B7-H1 has a relationship with carcinogenesis and MDR of gastric carcinoma by examining the expressions of B7-H1 in human gastric carcinoma cell hnes SGC7901/VCR, SGC7901, BGC-823 and in the permanent gastric epithelial cell line GES-1. Methods Cells were cultured in RPMI-1640 supplemented with 10% fetal calf serum. The B7-HI mRNA was detected by RT-PCR and the protein of B7-H1 was detected by cytoimmunoehemistry staining, cytoimmunofluoreseence staining and flow cytometric analysis. The expression levels of B7-H1 mRNA and the protein of B7-H1 in the above mentioned four kinds of cell lines were compared. Results All the four cell lines express B7-H1 mRNA at different levels. And B7-H1 expression level increased in the order of from GES-1 to SGC7901/VCR cell line, BGC-823 and then to SGC7901 cell line. The protein of B7-H1 was found to be distributed in the cell membrane and in a little cytoplasm in all the four cell lines through techniques of cytoimmunochemistry staining and cytoimmunochemistry staining. Further more with the result of flow cytometric analysis, the protein expression level of B7-H1 in all these cell lines was found to be consistent with B7-H1 transcript level expression. Conclusion The results suggest that B7-H1 expression on gastric epithelial cells may promote the growth of gastric carcinoma cells and the expression of MDR gene through inhibiting host immune responses.
出处 《解剖学报》 CAS CSCD 北大核心 2008年第1期70-73,共4页 Acta Anatomica Sinica
基金 教育部新世纪优秀人才支持计划(NECT-05-0609) 河南省重大科技攻关项目资助(0222031300)
关键词 B7-HI 多药耐药 逆转录-聚合酶链反应 胃癌细胞系 BT-H1 Multidrug resistance RT-PCR Gastric carcinoma cell lines
  • 相关文献

参考文献10

  • 1Dong H, Zhu G, Tamada K, et al. B7-H1,a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion[J]. Nat Med, 1999,5(12) : 1365-1369.
  • 2Das S, Suarez G, Beswick E, et al. Expression of B7-H1 on gastric epithelial cells : its potential role in regulating T cells during Helicobacter pylori infection[J]. J Immunol,2006, 176(5): 3000-3009.
  • 3Kanai T, Totsuka T, Uraushihara K, et al, Blockade of B7-H1 suppresses the development of chronic intestinal inflammation [ J ]. J Immunol,2003,171(8) :4156-163.
  • 4Waeckerle-Men Y, Starke A, Rudolf P. Wuthrich. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8^+ cytotoxic T cells[J]. Nephrol Dial Transplant ,2007,22(6) :1527-1536.
  • 5Tsushima F, Tanaka K, Otsuki N, et al. Predominant expression of B7-H1 and its immtmoregulatory roles in oral squamous cell carcinoma[ J ], Oral Oncol,2006,42(3) :268-274.
  • 6Ghebeh H, Mohamme S, Al-Omair A, et al. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factorsl [J]. Neoplasia,2006,8(3) : 190-198.
  • 7Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion[J]. Nat Med,2002,8(8) :793-800.
  • 8Strome BS, Dong H, Tamura H, et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma[ J ]. Cancer Res,2003,63(19) :6501-6505.
  • 9Hirano F, Kaneko K, Tamura H, et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity[ J ]. Cancer Res ,2005,65(3) : 1089-1096.
  • 10Norni T, Sho M, Akahori T, et al. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer [ J ]. Clin Cancer Res, 2007, 13 ( 7 ) : 2151- 2157.

同被引文献29

  • 1高福莲,蔡新华,马开颜,乐晓萍,张钦宪.mdr1基因在多药耐药相关的几种人胃癌细胞系的表达[J].中国现代医学杂志,2006,16(10):1490-1494. 被引量:6
  • 2Vilgelm A, Wei JX, Piazuelo MB, et al. DehaNp73alpha regulates MDR1 expression by inhibiting p53 function[J]. Oncogene, 2008,27 (15):2170-2176.
  • 3Oskeritzian CA, Zhao W, Min HK, et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell [J]. J Allergy Clin Immunol, 2005, 115(6):1162-1168.
  • 4朱德强,黄志勇.DNA损伤与肝癌发生[J].世界华人消化杂志,2007,15(16):1775-1780. 被引量:12
  • 5薛英威,韩继广,李宝馨,杨宝锋.三氧化二砷对胃癌细胞SGC7901多药耐药的逆转作用及其机制[J].药学学报,2007,42(9):949-953. 被引量:10
  • 6Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23t 515-548 .
  • 7Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26:677-704.
  • 8Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006; 27: 195-201.
  • 9Liu Z, Jiu J, Liu S, Fa X, Li F, Du Y. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion. J Autoimmun 2007; 29: 187-194.
  • 10Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimrnermann MC, David O, gurow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Ernilie D, Curiel DT, Chen L, Zou W. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003; 9: 562-567.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部